
Salesforce (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Salesforce (CRM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Unitree builds AI-powered robots that rival Tesla's Optimus units. Unitree raised more than $900 million with its IPO.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in Tutor Perini (TPC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 25.7% upside potential for Amphenol (APH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.6% in Amazon (AMZN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Optimism about a potential breakthrough in personalised cancer treatment has sent shares in Moderna soaring by nearly 100%. A late-stage trial of its experimental, vaccine-based treatment, called Intismeran, reduced skin cancer re-growth and stopped it spreading to other parts of the body. Intismeran combines an immunotherapy drug created by German pharmaceutical company Merck with a Moderna mRNA vaccine, a type of shot authorised widely to treat COVID-19.

Consistency matters more than ultra-high yields.

An overnight decline in yields accentuates as the U.S. Treasury says it will at least double the size of buyback operations for longer-dated bonds. The announcement follows a sharp selloff in long-term bonds that increased the government borrowing costs. The new buyback target takes effect September 9 through November 4, the Treasury says.

GM's relentless buyback machine crushed Ford and the S&P 500 for over a year, but something shifted in 2026 and now the tortoise is quietly pulling ahead. Before you bet on which automaker wins the next lap, the numbers tell a more complicated story than either bull case admits.

NOG's low valuation and strong free cash flow offer appeal, but leverage, commodity exposure and operator reliance keep the setup balanced.
Marvell shares hit an over one-month high in intra-day trade, while rival Broadcom’s stock took a hit.

TJX Companies Inc (NYSE:TJX) reported second-quarter profit and revenue above Wall Street estimates on Wednesday, as the off-price retailer's discount model continued to draw shoppers, though shares fell 1.3% at the open. The parent of TJ Maxx, Marshalls and HomeGoods posted adjusted earnings...

Here is how Acadian Asset Management (AAMI) and Citigroup (C) have performed compared to their sector so far this year.

Here is how Marten Transport, Ltd. (MRTN) and Norfolk Southern (NSC) have performed compared to their sector so far this year.

The 30-year Treasury yield fell nearly 9 basis points after hitting a 19-year high the prior session

LOW beats Q2 earnings estimates with tariff refunds helping results, while sales miss and DIY pressure lead to a narrower fiscal 2026 outlook.

The stock market was rallying Wednesday morning after the Treasury Department said it would double the size of long-dated debt buyback operations. The Nasdaq Composite was up 0.4%. The Treasury said it will double liquidity support operations for long-dated nominal coupon securities to $4 billion per operation starting Sept. 9 through Nov. 4.

The average brokerage recommendation (ABR) for KLA (KLAC) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

SK Hynix just approved the largest treasury share cancellation in South Korean stock market history, and the move is pulling the entire memory sector off its lows. The real question is whether record capital returns and record fab spending can coexist without one of them breaking.
Investing.com -- Marvell Technology Inc. shares rose nearly 11% in pre-market trading on Wednesday after the chipmaker announced a warrant agreement with Google linked to a custom chip partnership.

A single Phase 3 readout just shook the cancer treatment world, sending one biotech stock to its biggest single-day gain ever and forcing Wall Street to rethink whether personalized mRNA therapies have finally crossed the line from promising to proven.

Marvell Technology stock jumped after the chipmaker announced a deal to develop chips for Alphabet unit Google.

Safroadu Yeboah-Amankwah's $100,175 purchase signals confidence in the autonomous driving company despite the CEO stepping down.

Fortinet (NasdaqGS:FTNT) announced the acquisition of Virtue AI to support continuous AI runtime security for autonomous systems. The deal adds Virtue AI's continuous validation and real time protection tools to Fortinet's Security for AI strategy. Fortinet expects the Virtue AI technology to expand its security coverage across AI infrastructure and applications. Consider reviewing other companies building infrastructure and security around AI workloads through 56 AI infrastructure...

By Julie Steenhuysen and Christy Santhosh CHICAGO, Aug 19 (Reuters) - Moderna's personalized mRNA cancer therapy, developed with Merck, reduced the risk of melanoma recurrence and spread in a late-

Target Corp (NYSE:TGT) has raised its full-year outlook after reporting stronger-than-expected second quarter results. For the quarter, sales were up 5.3% year-over-year at $26.54 billion, ahead of Wall Street estimates of $26.13 billion. Comparable sales increased 3.8% year over year, while...

Shares of Estée Lauder advanced on Wednesday as the beauty and cosmetics giant’s better-than-expected quarterly earnings showed Wall Street its growth plan is well underway. The company announced adjusted earnings of 39 cents a share in the fiscal fourth quarter, up from 9 cents a year ago and above Wall Street’s expectation of 32 cents. Estée Lauder reported adjusted earnings of $2.51 a share for the full fiscal year, up from $1.51 last year.

The Hangzhou-based startup, founded in 2016, has quickly become something akin to a national champion in China's robotics sector.

Some of Wall Street's most legendary hedge fund managers quietly moved into SpaceX last quarter, but the size of those bets tells a story the headlines are missing.

Beauty products company Estée Lauder (NYSE:EL) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.4% year on year to $3.63 billion. Its non-GAAP profit of $0.39 per share was 23% above analysts’ consensus estimates.
Can we count your visit with Google Analytics? No ads, no profiles. Details